Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
Citi
Teva
US Army
Mallinckrodt
Federal Trade Commission
Queensland Health
Cerilliant

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 013295

« Back to Dashboard

NDA 013295 describes CONRAY 43, which is a drug marketed by Liebel-flarsheim and is included in one NDA. It is available from one supplier. Additional details are available on the CONRAY 43 profile page.

The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
Summary for 013295
Tradename:CONRAY 43
Applicant:Liebel-flarsheim
Ingredient:iothalamate meglumine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 013295
Mechanism of ActionX-Ray Contrast Activity
Medical Subject Heading (MeSH) Categories for 013295
Suppliers and Packaging for NDA: 013295
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CONRAY iothalamate meglumine INJECTABLE;INJECTION 013295 NDA Liebel-Flarsheim Company LLC 0019-0953 0019-0953-03 12 VIAL, GLASS in 1 BOX (0019-0953-03) > 100 mL in 1 VIAL, GLASS
CONRAY iothalamate meglumine INJECTABLE;INJECTION 013295 NDA Liebel-Flarsheim Company LLC 0019-0953 0019-0953-05 25 VIAL, GLASS in 1 BOX (0019-0953-05) > 50 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength60%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength43%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Citi
US Department of Justice
QuintilesIMS
Dow
Mallinckrodt
Colorcon
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.